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Hypothalamus proteomics from mouse models with obesity
and anorexia reveals therapeutic targets of appetite regulation
A Manousopoulou1,7, Y Koutmani2,7, S Karaliota2, CH Woelk1, ES Manolakos3,4, K Karalis2,4,8 and SD Garbis1,5,6,8
OBJECTIVE: This study examined the proteomic proﬁle of the hypothalamus in mice exposed to a high-fat diet (HFD) or with the anorexia
of acute illness. This comparison could provide insight on the effects of these two opposite states of energy balance on appetite regulation.
METHODS: Four to six-week-old male C56BL/6J mice were fed a normal (control 1 group; n= 7) or a HFD (HFD group; n= 10) for
8 weeks. The control 2 (n= 7) and lipopolysaccharide (LPS) groups (n= 10) were fed a normal diet for 8 weeks before receiving an
injection of saline and LPS, respectively. Hypothalamic regions were analysed using a quantitative proteomics method based on a
combination of techniques including iTRAQ stable isotope labeling, orthogonal two-dimensional liquid chromatography
hyphenated with nanospray ionization and high-resolution mass spectrometry. Key proteins were validated with quantitative PCR.
RESULTS: Quantitative proteomics of the hypothalamous regions proﬁled a total of 9249 protein groups (qo0.05). Of these,
7718 protein groups were proﬁled with a minimum of two unique peptides for each. Hierachical clustering of the differentiated
proteome revealed distinct proteomic signatures for the hypothalamus under the HFD and LPS nutritional conditions. Literature
research with in silico bioinformatics interpretation of the differentiated proteome identiﬁed key biological relevant proteins
and implicated pathways. Furthermore, the study identiﬁed potential pharmacologic targets. In the LPS groups, the anorexigen
pro-opiomelanocortin was downregulated. In mice with obesity, nuclear factor-κB, glycine receptor subunit alpha-4 (GlyR) and
neuropeptide Y levels were elevated, whereas serotonin receptor 1B levels decreased.
CONCLUSIONS: High-precision quantitative proteomics revealed that under acute systemic inﬂammation in the hypothalamus as
a response to LPS, homeostatic mechanisms mediating loss of appetite take effect. Conversely, under chronic inﬂammation in the
hypothalamus as a response to HFD, mechanisms mediating a sustained ‘perpetual cycle’ of appetite enhancement were observed.
The GlyR protein may constitute a novel treatment target for the reduction of central orexigenic signals in obesity.
Nutrition & Diabetes (2016) 6, e204; doi:10.1038/nutd.2016.10; published online 25 April 2016
INTRODUCTION
Overweight and obesity as a result of positive energy balance
constitute major public health burdens with signiﬁcant economic
and social implications.1 The hypothalamus is the key brain site for
the regulation of food intake and energy balance in mammals.
Under physiological conditions, a variety of peripheral signals
regulate appetite and adjust energy intake to match energy
consumption requirements.2 Systemic acute inﬂammatory signals
can cause profound anorexia by disrupting the physiological
regulation of appetite in the hypothalamus.3 Conversely, emer-
ging evidence suggests that hypothalamic ‘inﬂammatory’ activa-
tion as a result of a high-fat diet (HFD) and obesity can disturb
anorexigenic and thermogenic signals and promote abnormal
body weight control.4 Deciphering the molecular events of these
two contradictory observations in a global and directly compara-
tive way allows for a more causal understanding on the relations
between diet, inﬂammatory signals and appetite regulation.
Provided that nutritional intervention protocols are likely to
interfere with multiple pathways inside the cell, a system-wide
interrogation of the host response using non-targeted quantita-
tive proteomics was warranted.5
The aim of this study was to compare the global proteomic
proﬁle of the hypothalamus in mice exposed to a HFD or with
anorexia of acute illness. We hypothesise that such a comparison
can shed new insight on the effects of these two opposite states
of energy balance on appetite regulation.
MATERIALS AND METHODS
Animal model
Studies were conducted in male mice on C56BL/6J background. Mice
were bred and maintained at regular housing temperatures (23 °C) and
12-h light/dark cycle starting at 0700 hours. Animals had ad libitum
access to water and food and were weighed at weekly intervals. Four to
six-week-old mice (n = 34) were randomly divided into four groups: the
control 1 (C1) group (n = 7), the HFD group (n = 10), the control 2 (C2)
group (n = 7) and the lipopolysaccharide (LPS) group (n = 10). Mice in the
C1 group were fed a control diet (4.5% fat, 34% starch, 5.0% sugar and
22.0% protein), whereas the HFD group was fed a HFD (24% fat, 41%
carbohydrate, and 24% protein; Research diets D12451 formula) for
8 weeks after which they were anaesthetised and perfused intracardially
with phosphate-buffered saline. A diet containing 24% fat (45% kcal fat)
was selected because it efﬁciently induces obesity and better simulates
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a human HFD as opposed to a more extreme 60% kcal fat diet.6,7 Mice in
the C2 and LPS groups were fed a control diet for 8 weeks. After this
period, mice in the C2 group received an intraperitoneal injection of
0.3 ml saline, whereas in the LPS group received an intraperitoneal
injection of LPS (Escherichia coli O111:B4 (Sigma No. L-2630)) at a dose of
120 μg per mouse dissolved in 0.3 ml saline. Mice in the C2 and LPS
groups were killed 18 h after the injection as described above. As protein
expression in the hypothalamus is known to be under circadian
regulation,8 mice were killed at 0700 hours. Experimental procedures
were approved by the Institutional Animal Care and Use Committee at
the Centre of Basic Research, Biomedical Research Foundation of the
Academy of Athens.
Determination of insulin resistance by HOMA-IR
HOMA-IR analysis was used to assess insulin resistance in HFD-fed mice.
After overnight fasting, values for homeostasis model assessment of insulin
resistance (HOMA-IR) were calculated from the values of fasting serum
glucose (mg dl− 1) and fasting serum insulin (μU ml− 1) by using the
following formula: HOMA-IR= fasting glucose value (mg dl− 1) × fasting
insulin value (μU ml− 1)/405. Low HOMA-IR values indicate high insulin
sensitivity, whereas high HOMA-IR values indicate low insulin sensitivity
(insulin resistance). Fasting glucose concentrations were measured using a
hand-held glucometer (Biorad, Hercules, CA, USA), whereas serum insulin
levels were quantiﬁed by ELISA (Mercodia, Uppsala, Sweden).
Quantitative proteomics sample processing
Hypothalamic regions were removed and snap frozen at − 80 °C. Speci-
mens were dissolved in 0.5 M triethylammonium bicarbonate, 0.05%
sodium dodecyl sulphate, homogenised using the Fast Prep system
(Savant Bio, Cedex, France) followed by pulsed probe sonication (Misonix,
Farmingdale, NY, USA). Lysates were centrifuged (16 000 g, 10 min, 4 °C)
and supernatants were measured for protein content using infra-red
spectroscopy (Merck Millipore, Darmstadt, Germany). For the quantitative
proteomic analysis, the hypothalamic regions from three mice were used for
the C1 and C2 groups and from six mice for the HFD and LPS groups (n=18
in total). Three individual protein extracts were pooled (33.3 μg from each
lysate giving 100 μg ﬁnal protein content) to form one sample for the C1 and
C2 groups and two biological replicates for the HFD and LPS groups. Lysates
were then reduced, alkylated and subjected to trypsin proteolysis. Peptides
were labelled using six of the eight-plex iTRAQ reagent kit (113=C1,
114=C2, 115=HFD1, 116=HFD2, 117= LPS1, 118= LPS2) and analysed
using high-precision two-dimensional liquid chromatography with nanos-
pray ionization tandem mass spectrometry as reported previously by the
authors9–12 (Figure 1a) (Supplementary Methods 1).
Database searching
Unprocessed raw ﬁles were submitted to Proteome Discoverer 1.4 for
target decoy searching against the UniProtKB/TrEMBL mus musculus
database comprised of 57 475 entries (release date 03 September 2014),
allowing for up to two missed cleavages, a precursor mass tolerance of
10 ppm, a minimum peptide length of six and a maximum of two variable
(one equal) modiﬁcations of; iTRAQ 8-plex (Y), oxidation (M), deamidation
(N, Q) or phosphorylation (S, T, Y). Methylthio (C) and iTRAQ (K, N terminus)
were set as ﬁxed modiﬁcations. Reporter ion ratios from unique peptides
only were taken into consideration for the quantitation of the respective
protein. Quantiﬁcation ratios were median-normalised and log2 trans-
formed. Proteins were grouped using the protein grouping inference
algorithm in the Proteome Discoverer 1.4 application (Supplementary
Methods 2). A protein was considered modulated in the HFD or LPS group
relative to control when its log2 ratio was above or below± 1 s.d. across
both biological replicates.13 In adherence to the Paris Publication
Guidelines for the analysis and documentation of peptide and protein
identiﬁcations (http://www.mcponline.org/site/misc/ParisReport_Final.xhtml)
and the recently published guidelines for high-conﬁdence protein identiﬁca-
tion by Omenn et al.,14 only proteins identiﬁed with at least two unique
peptides were further subjected to bioinformatics analysis. Proteins of
biological relevance, two of which were identiﬁed with one unique peptide,
were validated using targeted quantitative PCR. Proteomics data were
deposited to the ProteomeXchange Consortium via the PRIDE partner
repository with the dataset identiﬁer PXD003475.
Bioinformatics analysis
Heatmap construction of differentially expressed proteins in the HFD and
LPS groups compared with their respective control was generated using
Cluster 3.0 (http://bonsai.hgc.jp/ ~mdehoon/software/cluster/software.htm)
and Java Treeview (http://jtreeview.sourceforge.net). MetaCore (GeneGo,
St Joseph, MI, USA) and BiNGO were applied to differentially expressed
proteins analysed with at least two unique peptides to identify over-
represented processes in the modulated proteome of each group compared
with their respective control. FDR-corrected P-values o0.05 were considered
signiﬁcant.
Total RNA isolation and cDNA synthesis
For the quantitative PCR analysis the hypothalamic regions from four mice
were utilised per group (C1, C2, HFD, LPS) (n= 16 in total). Total RNA from
mouse hypothalamus was extracted using an RNA Isolation Kit (Qiagen,
Hilden, Germany) according to the manufacturer's instructions. RNA
concentration and purity were determined by NanoDrop 2000c Spectro-
photometer (Thermo Scientiﬁc, Waltham, MA, USA). Ribosomal RNA band
integrity was evaluated by conventional 1% agarose gel electrophoresis
and the Agilent Bioanalyzer with the RNA 6000 Nano Kit (Agilent, Santa
Clara, CA, USA).
For complementary DNA (cDNA) synthesis, 300 ng total RNA from each
sample was reverse transcribed into cDNA using M-MLV Reverse Tran-
scriptase (Thermo Scientiﬁc) according to the manufacturer's instructions. All
the cDNA samples were stored at − 20 °C until quantitative PCR analyses.
Quantiﬁcation of mRNA
Quantiﬁcation of mRNA was performed for the following proteins: NFκ-Β,
neuropeptide Y (NPY), 5-hydroxytryptamine (serotonin) receptor 1B, glycine
receptor alpha-4 subunit, pro-opiomelanocortin. The PCR mixture contained
1 μl diluted cDNA, 10 μM gene-speciﬁc primer (forward and reverse mixed
together) and 10 μl of 2× Fast SYBR Green Master Mix (Roche Diagnostics,
Rotkreuz, Switzerland) in a total volume of 20 μl. Ampliﬁcation was
performed in 96-well optical reaction plates (Roche Diagnostics) on
LightCycler 480 (Roche Diagnostics) using the following programme: 94 °C
for 3 min to activate polymerase, 40 cycles at 94 °C for 20 s, 60 °C for 20 s
and 72 °C for 20 s; melting curve analysis was performed after every run by
heating up to 95 °C to monitor presence of unspeciﬁc products. Two
negative controls were included in each assay run, with water instead of
template. Three replicate measurements for each sample were performed.
Primers were designed and checked with Primer Quest Tool (IDT) and NCBI
primer BLAST tool and synthesised by Macrogen (Seoul, South Korea). Primer
sequences are listed in Supplementary Table 1.
Quantitative PCR data analysis
The mRNA expression of genes in the hypothalamus of LPS-treated and
HFD-fed mice was calculated relative to the expression in their respective
control mice, according to the delta–delta Ct method (2−ΔΔCt) using
the most and least stable reference genes found, as well as the
most commonly used glyceraldehyde-3-phosphate dehydrogenase and
beta-actin.
RESULTS
Mice fed a HFD weighed signiﬁcantly more than those fed a control
diet (Supplementary Figure 1A). Furthermore, they were insulin
resistant with signiﬁcantly higher HOMA-IR values (Supplementary
Figure 1B). The proteomic analysis of the hypothalamic regions
resulted in the proﬁling of 9249 protein groups (qo0.05)
(Supplementary Tables 2 and 3), of which 7718 were identiﬁed
with at least two unique peptides. Among the proteins identiﬁed
with at least two unique peptides, 201 were upregulated in the
HFD and 193 in the LPS groups compared with their respective
control, of which 30 were common between the two conditions.
Furthermore, 169 proteins were downregulated in the HFD and
194 in the LPS groups, of which 18 were common between the
two conditions (Figure 1b, Supplementary Tables 4–6). The R2 value
between biological replicates was 0.69 and 0.89 for the differentially
expressed proteins of the HFD and LPS groups, respectively.
Hierarchical clustering of the differentiated proteome revealed a
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distinct proteomic signatures of the hypothalamus under the HFD
and LPS (Figure 1c) nutritional conditions.
Gene ontology analysis using BiNGO of the 48 commonly
modulated proteins showed a signiﬁcant enrichment for acute
inﬂammatory response (Figure 1d). In the hypothalamus of the LPS-
exposed mice protein folding and maturation_posttranslational
processing of neuroendocrine peptides (FDR-corrected P-value=1.2E-6)
(Figure 2a) and apoptosis and survival_caspase cascade (FDR-
corrected P-value = 1.8E-2) (Figure 2b) were signiﬁcantly enriched.
In the differentially expressed proteins of the HFD groups,
inﬂammation_IL-6 signalling (FDR-corrected P-value = 6.5E-6)
(Figure 3a), inﬂammation_kallikrein-kinin system (FDR-corrected
P-value = 9.3E-6), and inﬂammation_protein C signalling (FDR-
corrected P-value= 9.2E-3) were signiﬁcantly over-represented.
A nodal protein in all three inﬂammatory pathways was NF-κB,
analysed to increase in the HFD groups compared with control
(Figure 1c). Gene ontology analysis using BiNGO conﬁrmed that
both acute and chronic inﬂammatory responses were signiﬁcantly
over-represented in the modulated proteome of the hypothala-
mus in HFD-fed mice compared with control (Figure 3b).
Of potential biomedical interest to be discussed, nuclear factor-
κB (NF-κB), pro-NPY and glycine receptor alpha-4 subunit levels
increased, whereas serotonin receptor 1B levels were reduced in
the HFD groups relative to control. In the LPS groups compared
with control, pro-opiomelanocortin was proﬁled to be down-
regulated. The relative quantitation of these proteins at the mRNA
level was validated using quantitative PCR (Figure 4).
DISCUSSION
Molecular perturbations in the hypothalamus as a result of obesity
have been studied primarily at the transcriptome but not the
proteome level.15,16 This study compared the global proteomic
proﬁle of the mouse hypothalamus between two experimental
groups in opposite states of energy balance, that is, mice with
increased caloric intake through a HFD, versus mice with severely
compromised food intake due to acute systemic inﬂammation.
Acute inﬂammatory response was signiﬁcantly enriched in the
commonly modulated proteins of both groups (Figure 1d), in
agreement with a number of studies indicating the altered
‘inﬂammatory’ state in these experimental models.3,17
Figure 1. (a) Overview of the proteomics pipeline (b) Venn diagram description of the differentiated proteins between the HFD and LPS
groups relative to their respective controls. (c) Hierarchical clustering analysis of modulated proteins: the HFD and LPS groups have a distinct
endophenotypic portrait in the hypothalamus. (d) Gene ontology analysis using BiNGO of the commonly modulated proteins in the HFD and
LPS conditions compared with their respective control showed a signiﬁcant enrichment for acute inﬂammatory response. Coloured nodes
representing GO terms correspond to those that were signiﬁcant according to the P-value colour scale, whereas white nodes were not
signiﬁcant. The size of the node reﬂects the number of proteins that mapped to the corresponding GO term.
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It is well established that LPS induces anorexia in mouse
models.18 Our results showed that the acute systemic inﬂamma-
tory response caused by LPS treatment speciﬁcally decreased pro-
opiomelanocortin (Figure 4) and the related ACTH and alpha-MSH
peptides with well-shown anorexigenic effects (Figure 2a). This
paradoxical downregulation of anorexigenic signals possibly high-
lights the presence of a negative feedback loop, aiming to re-
establish homoeostasis. Furthermore, hypothalamic sampling was
done 18 h after LPS administration, as the mice were recovering
from the endotoxin effects, as the administered LPS dose was at
a medium range. Along this theme, reduced expression levels of
caspase isoforms 3, 6 and 7 in the hypothalamus of LPS-treated mice
was observed (Figure 2b). This ﬁnding suggests control of apoptotic
processes and protection of neurons during re-establishment
of homoeostasis, supporting the theory that inﬂammatory and
homoeostatic control mechanisms may antagonise in a time- and
immune activation phase-dependent manner.19
In the modulated proteome of the HFD groups, a number of
inﬂammatory pathways, including the IL-6 pathway (Figure 3a),
kallikrein-kinin system and protein C signalling, were signiﬁcantly
enriched, reﬂecting a more pronounced, chronic inﬂammatory
response, also evident in the gene ontology analysis (Figure 3b).
Protein folding and maturation_Posttranslational processing of neuroendocrine peptides Apoptosis and survival_Caspase cascade 
Figure 2. In silico analysis using MetaCore showed that (a) protein folding and maturation_posttranslational processing of neuroendocrine
peptides (FDR-corrected P-value= 1.2E-6) and (b) apoptosis and survival_caspase cascade (FDR-corrected P-value= 1.8E-2) were signiﬁcantly
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Figure 3. (a) In silico analysis using MetaCore showed that inﬂammation_IL-6 signalling was signiﬁcantly enriched in the differentially
expressed proteins of the HFD groups compared with control (FDR-corrected P-value= 6.5E-6). Analysed proteins are denoted with a circle
(red=upregulation, blue=downregulation). (b) Gene ontology analysis using BiNGO conﬁrmed that acute and chronic inﬂammatory
responses are signiﬁcantly enriched in the differentially expressed hypothalamic proteins of HFD-fed mice compared with control. Coloured
nodes representing GO terms correspond to those that were signiﬁcant according to the P-value colour scale, whereas white nodes were not
signiﬁcant. The size of the node reﬂects the number of proteins that mapped to the corresponding GO term.
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Upregulation of pro-inﬂammatory mediators in the hypothalamus
is a hallmark of obesity and constitutes a major component of
insulin resistance pathogenesis.20 The exact mechanisms mediating
this phenotype remain a subject of intense investigation with
endoplasmic reticulum stress, oxidative stress or direct activation of
inﬂammatory-related transcription factors among the implicated
processes.
A central node in the hypothalamic inﬂammatory processes
was NF-κB, found to be upregulated as a result of HFD (Figure 4).
NF-κB, an important mediator of metabolic inﬂammation, is
enriched in hypothalamic neurons but normally remains
inactive.21 Over-nutrition alone, even before the onset of obesity,
activates hypothalamic NF-κB partly through increased endoplas-
mic reticulum stress.21 Furthermore, activation of hypothalamic
NF-κB interrupts central insulin and leptin signalling and actions,
whereas local suppression in the mediobasal hypothalamus, or
more speciﬁcally in hypothalamic Agouti-related peptide neurons,
signiﬁcantly protects against obesity and glucose intolerance.21
NPY was proﬁled to increase in the hypothalamus of HFD-fed
mice compared with control (Figure 4). Central administration of
NPY, a well-established orexigenic peptide in the hypothalamus,22
has been found to increase food intake and body weight, with
chronic administration leading to development of obesity.23,24
Furthermore, NPY overexpression in the dorsomedial hypothala-
mus induces hyperphagia and obesity,25,26 whereas knockdown of
NPY improves these changes.27,28 A recent study showed that
dorsomedial hypothalamus NPY knockdown rats on HFD had
normal food intake, body weight and glucose tolerance/insulin
sensitivity indexes as observed in lean control rats.28 These
authors suggest that dorsomedial hypothalamus NPY could be a
potential therapeutic target for obesity and diabetes.
In the hypothalamus of HFD-fed mice compared with control,
levels of serotonin receptor 1B (5-hydroxytryptamin receptor 1B;
5-HT1BR), a key modulator of energy homeostasis and a therapeutic
target for obesity, were analysed to decrease (Figure 4). Serotonin
reduces the activity of the orexigenic AgRP/ΝPY neurons via the
5-HT1BR in mice (or 5-HT1DBR in humans).29 Studies have shown
that mice lacking the 5-HT1BR develop hyperphagia, resulting in
body weight increase.30 In addition, administration of CP-94,253, a
highly selective 5-HT1BR agonist, signiﬁcantly decreases food intake31
and potentiates the anorectic effects of pro-opiomelanocortin.
GlyR was analysed to be upregulated in the hypothalamus of
mice with obesity compared with control (Figure 4). Although
glycine is a well-established inhibitory neurotransmitter in the spinal
cord and brain stem,32 studies examining the function of glycine
receptors in higher brain structures including the hypothalamus
are limited. A study by Karnani et al.33 showed that glycine receptor
agonists exert a hyperpolarizing action on mature hypocretin/orexin
(hcrt/orx) neurons in the hypothalamus, important regulators
of arousal and reward seeking behaviour. To the best of our
knowledge, our study is the ﬁrst to identify an increase of GlyR levels
in the hypothalamus of mice exposed to HFD. GlyR receptor
antagonists, could be tested for their efﬁcacy to reduce central
orexigenic signals in obesity.
CONCLUSION
High-precision quantitative proteomics revealed that under acute
systemic inﬂammation in the hypothalamus as a response to LPS,
homeostatic mechanisms mediating loss of appetite take effect.
Conversely, under chronic inﬂammation in the hypothalamus as
a response to HFD, mechanisms mediating a sustained ‘perpetual
cycle’ of appetite enhancement were observed. The combinatorial
protein level modulation of the NF-κB, 5-HT1BR, GlyR and pro-NPY
provides strong evidence for the enhancement of orexigenic
signals as a response to HFD. Our study is the ﬁrst to identify an
increase of GlyR levels in the hypothalamus of mice exposed to
HFD. Antagonists for this receptor could be tested for their efﬁcacy
to reduce central orexigenic signals in obesity.
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